Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Gene vaccination shows potential against allergy

Feb. 24, 1997

Correlation between asthma and IL-10

Feb. 24, 1997

Method of treating allergies and HIV offered for licensing

Feb. 24, 1997

NIH seeks licensees for method of treating allergies and HIV

Feb. 24, 1997

Antisense compound for asthma shows promise

Feb. 21, 1997

Efficacy of leukotriene antagonist in asthma

Feb. 19, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Positive phase II results reported for LiquiVent

Feb. 12, 1997

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...